Drug related oro-facial disease (CROSBI ID 524751)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Alajbeg, Ivan ; Hodgson, Tim
engleski
Drug related oro-facial disease
Drugs may be defined as substances used in the diagnosis, treatment, or prevention of a disease or as a component of a medication or alternatively as chemical substances, such as a narcotic or hallucinogen, affecting the central nervous system, causing changes in behavior and often addiction. Orofacial drug-related adverse reactions may present initially to the dental surgeon or doctor and require specialist opinion. Due to the complexity of clinical presentation including symptoms (pain, dysgeusia, xerostomia and dysaesthesia) and signs (mucosal and bone pathology) diagnostic problems are common and a detailed prescribed and non – prescribed medication history invalid. New therapeutic interventions are continually introduced across Europe and health care practitioners should be vigilant for unreported oro-facial adverse reactions and be able to access the local reporting mechanism. The benefits of the drug prescribed weighed against the risk from the oro-facial adverse reaction will determine if drug cessation is appropriate. This paper aims to update practitioners on the spectrum of drug-related oro-facial disease, review factors to be elicited from the drug history, focus on newly introduced drugs and their, in some cases devastating, oro-facial adverse effects and discuss management options.
oral lesions; oral symptoms; drugs; adverse reactions
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
3-x.
2006.
objavljeno
Podaci o matičnoj publikaciji
Oral Diseases
Mravak-Stipetić, Marinka ; Alajbeg, Ivan ; Brailo, Vlaho
Oxford: Blackwell Publishing
Podaci o skupu
8th Biennial Congress of the European Association of Oral Medicine.
pozvano predavanje
31.08.2006-02.09.2006
Zagreb, Hrvatska